Research Areas

A Randomized, Open-Label Parallel Group Phase 2b Trial Evaluating Safety and Efficacy of An Investigational Insulin Compared to Humalog Mix 75/25 in Subjects With Type 2 Diabetes.

Glycemic Control and Treatment Satisfaction Using An Insulin Delivery System Versus Pen for Initiating Bolus Insulin Dosing in Patients with Type 2 Diabetes Mellitus (T2DM) Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents (AHAs).

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of An Investigational Insulin in Adult Patients with Type 2 Diabetes Mellitus who are Inadequately Controlled with Diet and Metformin.

Dose-Finding of An Investigational Medication Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes: A 26-week, Multicentre, Double-Blind, Randomised, Controlled Dose-Finding Trial

Phase 2a Multicenter, Randomized, Double-Blind, Placebo Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of An Investigational Medication Injection in Adult Subjects with Type 2 Diabetes Mellitus.

Safety and Efficacy of An Approved Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects with Type 2 Diabetes Mellitus: A Randomized, Open-Label, Parallel Clinical Trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of An Investigational Medication as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control with Insulin Therapy.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety and Tolerability Trial of Once Daily, Oral Doses of An Investigational Medication as Adjunctive to Insulin Therapy Over 52 Weeks in Patients with Type 1 Diabetes Mellitus.

Efficacy and Safety of An Investigational Fast Acting Insulin Aspart Compared to NovoRapid Both in Combination With Insulin Degludec in Adults with Type 1 Diabetes

A Phase 2a Randomized, Double-Blind, Multicenter, Placebo and Active Controlled Study to Assess Analgesic Efficacy and Safety of An Investigational Medication in Subjects with Painful Diabetic Peripheral Neuropathy.

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of An Investigational Medication in Subjects With Painful Diabetic Peripheral Neuropathy.

A 6-Month Safety Study of An Investigational Medication Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism

Validation of Dosing Regimen of An Investigational Oral Testosterone In Hypogonadal Men

A 12-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability and Actual Use of An Investigational Medication and An Autoinjector (Pre-Filled Pen) in Subjects with Primary Hyperlipidemia or Mixed Dyslipidemia.

Randomized Evaluation of An Investigational Medication to Suppress LDL Cholesterol in Patients with Dyslipidemia

A Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Adding An Investigational Medication to 180 MG to Atorvastatin 80 MG Background Therapy in Statin-Treated Patients.

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of An Investigational Nasal Spray in Adolescents and Adults with Cluster Seizures.

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of An Approved Medication as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects with Idiopathic Generalized Epilepsy.

An Open Label, Multicenter, Safety and Pharmacokinetic Study of An Investigational Medication as Adjunctive Therapy in Subjects with Partial Onset Seizures

Clinical Study of Perceived Pain with A Blood Glucose Monitoring System Compared to Two Other Marketed Blood Glucose Monitoring Systems.